# S.I.P.R.E.S. Srl – FDA Inspection, Sep 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/sipres-srl/4dd10e92-8fb1-4f72-bb29-aac62114183d
Source feed: FDA_Inspections

> FDA inspection 1102859 of S.I.P.R.E.S. Srl, September 26, 2019. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102859
- Company Name: S.I.P.R.E.S. Srl
- Inspection Date: 2019-09-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1259898 - 2025-01-23](https://www.keypedia.com/records/fda_inspections/sipres-srl/587b6f19-de52-4e1e-9144-5e28bbeb4d4f)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/sipres-srl/fc69840e-d40d-4068-9aa8-e166c37124df

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c